These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1555581)

  • 41. Key role of the 3' untranslated region in the cell cycle regulated expression of the Leishmania infantum histone H2A genes: minor synergistic effect of the 5' untranslated region.
    Abanades DR; Ramírez L; Iborra S; Soteriadou K; González VM; Bonay P; Alonso C; Soto M
    BMC Mol Biol; 2009 May; 10():48. PubMed ID: 19460148
    [TBL] [Abstract][Full Text] [Related]  

  • 42. H2A.X. a histone isoprotein with a conserved C-terminal sequence, is encoded by a novel mRNA with both DNA replication type and polyA 3' processing signals.
    Mannironi C; Bonner WM; Hatch CL
    Nucleic Acids Res; 1989 Nov; 17(22):9113-26. PubMed ID: 2587254
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cloning and characterization of the major histone H2A genes completes the cloning and sequencing of known histone genes of Tetrahymena thermophila.
    Liu X; Gorovsky MA
    Nucleic Acids Res; 1996 Aug; 24(15):3023-30. PubMed ID: 8760889
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cloning, expression, and purification of a novel recombinant antigen from Leishmania donovani.
    Sivakumar R; Sharma P; Chang KP; Singh S
    Protein Expr Purif; 2006 Mar; 46(1):156-65. PubMed ID: 16172002
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dogs vaccinated with gentamicin-attenuated Leishmania infantum or infected with wild-type parasite can be distinguished by Western blotting.
    Daneshvar H; Mahmmodi Z; Kamiabi H; Phillips RS; Burchmore R
    Parasite Immunol; 2014 May; 36(5):218-24. PubMed ID: 24611833
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
    Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
    Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular and Serological Evidence of Leishmania Infection in Stray Dogs from Visceral Leishmaniasis-Endemic Areas of Bangladesh.
    Akter S; Alam MZ; Nakao R; Yasin G; Kato H; Katakura K
    Am J Trop Med Hyg; 2016 Oct; 95(4):795-799. PubMed ID: 27382083
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative evaluation of enzyme-linked immunosorbent assays based on crude and recombinant leishmanial antigens for serodiagnosis of symptomatic and asymptomatic Leishmania infantum visceral infections in dogs.
    Porrozzi R; Santos da Costa MV; Teva A; Falqueto A; Ferreira AL; dos Santos CD; Fernandes AP; Gazzinelli RT; Campos-Neto A; Grimaldi G
    Clin Vaccine Immunol; 2007 May; 14(5):544-8. PubMed ID: 17314229
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Isolation and characterization of a repetitive DNA sequence from Leishmania infantum: development of a visceral leishmaniasis polymerase chain reaction.
    Piarroux R; Azaiez R; Lossi AM; Reynier P; Muscatelli F; Gambarelli F; Fontes M; Dumon H; Quilici M
    Am J Trop Med Hyg; 1993 Sep; 49(3):364-9. PubMed ID: 8372958
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular and immunological characterisation of the glucose regulated protein 78 of Leishmania donovani(1).
    Jensen AT; Curtis J; Montgomery J; Handman E; Theander TG
    Biochim Biophys Acta; 2001 Sep; 1549(1):73-87. PubMed ID: 11566370
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of new antigens in visceral leishmaniasis by expression cloning and immunoblotting with sera of kala-azar patients from Bihar, India.
    Theinert SM; Basu R; Forgber M; Roy S; Sundar S; Walden P
    Infect Immun; 2005 Oct; 73(10):7018-21. PubMed ID: 16177384
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cloning of the gene encoding Leishmania donovani S-adenosylhomocysteine hydrolase, a potential target for antiparasitic chemotherapy.
    Henderson DM; Hanson S; Allen T; Wilson K; Coulter-Karis DE; Greenberg ML; Hershfield MS; Ullman B
    Mol Biochem Parasitol; 1992 Jul; 53(1-2):169-83. PubMed ID: 1501636
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vaccination of dogs with six different candidate leishmaniasis vaccines composed of a chimerical recombinant protein containing ribosomal and histone protein epitopes in combination with different adjuvants.
    Poot J; Janssen LH; van Kasteren-Westerneng TJ; van der Heijden-Liefkens KH; Schijns VE; Heckeroth A
    Vaccine; 2009 Jul; 27(33):4439-46. PubMed ID: 19500553
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression and characterization of a recombinant kinesin antigen from an old Indian strain (DD8) of Leishmania donovani and comparing it with a commercially available antigen from a newly isolated (KE16) strain of L. donovani.
    Sivakumar R; Dey A; Sharma P; Singh S
    Infect Genet Evol; 2008 May; 8(3):313-22. PubMed ID: 18374635
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phlebotomus perfiliewi transcaucasicus is circulating both Leishmania donovani and L. infantum in northwest Iran.
    Oshaghi MA; Ravasan NM; Hide M; Javadian EA; Rassi Y; Sadraei J; Mohebali M; Sedaghat MM; Hajjaran H; Zarei Z; Mohtarami F
    Exp Parasitol; 2009 Nov; 123(3):218-25. PubMed ID: 19631209
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Leishmania donovani: identification of novel vaccine candidates using human reactive sera and cell lines.
    Arora SK; Pal NS; Mujtaba S
    Exp Parasitol; 2005 Mar; 109(3):163-70. PubMed ID: 15713447
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The FML-vaccine (Leishmune) against canine visceral leishmaniasis: a transmission blocking vaccine.
    Saraiva EM; de Figueiredo Barbosa A; Santos FN; Borja-Cabrera GP; Nico D; Souza LO; de Oliveira Mendes-Aguiar C; de Souza EP; Fampa P; Parra LE; Menz I; Dias JG; de Oliveira SM; Palatnik-de-Sousa CB
    Vaccine; 2006 Mar; 24(13):2423-31. PubMed ID: 16386824
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Production and characterization of monoclonal antibodies recognizing a common 57-kDa antigen of Leishmania species.
    Nejad-Moghaddam A; Abolhassani M
    Iran Biomed J; 2009 Oct; 13(4):245-51. PubMed ID: 19946351
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The mRNA coding for the nucleosomal protein H2A of Leishmania is polyadenylated and has stem-loops at the 3' end.
    Soto M; Requena JM; Jimenez-Ruiz A; Alonso C
    Nucleic Acids Res; 1991 Aug; 19(16):4554. PubMed ID: 1679534
    [No Abstract]   [Full Text] [Related]  

  • 60. Vaccination with a plasmid DNA cocktail encoding the nucleosomal histones of Leishmania confers protection against murine cutaneous leishmaniosis.
    Iborra S; Soto M; Carrión J; Alonso C; Requena JM
    Vaccine; 2004 Sep; 22(29-30):3865-76. PubMed ID: 15364433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.